Gene expression profile and genomic changes in disease progression of early-stage chronic lymphocytic leukemia

Haematologica

Volumn 93, Issue 1, 2008, Pages 132-136

  Fernàndez, Verònica ^a   Jares, Pedro ^a   Salaverria, Itziar ^a   Giné, Eva ^a   Beà, Sílvia ^a   Aymerich, Marta ^a   Colomer, Dolors ^a   Villamor, Neus ^a   Bosch, Francesc ^a   Montserrat, Emili ^a   Campo, Elias ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Chronic lymphocytic leukemia; Comparative genomic hybridization; Microarrays; Progression

Indexed keywords

CORTICOSTEROID; CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL ADHESION; CELL MOTILITY; CHROMOSOME 12; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE COURSE; DOWN REGULATION; FEMALE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MALE;

AGED; AGED, 80 AND OVER; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENOME; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 38549181631     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.11694     Document Type: Article

References (17)

1. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804-15.
2. Bea S, Lopez-Guillermo A, Ribas M, Puig X, Pinyol M, Carrio A, et al. Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome). Am J Pathol 2002;161:957-68.
3. Cobo F, Martinez A, Pinyol M, Hernandez L, Gomez M, Bea S, et al. Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemia. Leukemia 2002; 16:1028-34.
4. Cordone I, Masi S, Mauro FR, Soddu S, Morsilli O, Valentini T, et al. p53 expression in B-cell chronic lymphocytic leukemia: a marker or disease progression and poor prognosis. Blood 1998;91:4342-9.
5. Pinyol M, Cobo F, Bea S, Jares P, Nayach I, Fernandez PL, et al. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 1998;91:2977-84.
6. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990-7.
7. Binet JL, Caligaris-Cappio F, Catovsky D, Cheson B, Davis T, Dighiero G, et al. Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia. Blood 2006;107:859-61.
8. Crespo M, Bosch F, Villamor N, Bellosillo B, Colomer D, Rozman M, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 2003; 348:1764-75.
9. Pinyol M, Hernandez L, Martinez A, Cobo F, Hernandez S, Bea S, et al. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene. Am J Pathol 2000;156:1987-96.
10. Smyth GK. Linear Models and Empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biology 2004;3.
11. Krober A, Bloehdorn J, Hafner S, Buhler A, Seiler T, Kienle D, et al. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia. J Clin Oncol 2006;24:969-76.
12. Callet-Bauchu E, Salles G, Gazzo S, Poncet C, Morel D, Pages J, et al. Translocations involving the short arm of chromosome 17 in chronic B-lymphoid disorders: frequent occurrence of dicentric rearrangements and possible association with adverse outcome. Leukemia 1999;13:460-8.
13. Peterson LC, Lindquist LL, Church S, Kay NE. Frequent clonal abnormalities of chromosome band 13q14 in B-cell chronic lymphocytic leukemia: multiple clones, subclones, and nonclonal alterations in 82 midwestern patients. Genes Chromosomes Cancer 1992;4:273-80.
14. Stilgenbauer S, Bullinger L, Lichter P, Dohner H. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course. Leukemia 2002;16:993-1007.
15. Falt S, Merup M, Gahrton G, Lambert B, Wennborg A. Identification of progression markers in B-CLL by gene expression profiling. Exp Hematol 2005;33:883-93.
16. Haran M, Chebatco S, Flaishon L, Lantner F, Harpaz N, Valinsky L, et al. Grb7 expression and cellular migration in chronic lymphocytic leukemia: a comparative study of early and advanced stage disease. Leukemia 2004;18:1948-50.
17. Richardson SJ, Matthews C, Catherwood MA, Alexander HD, Carey BS, Farrugia J, et al. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL). Blood 2006; 107:3584-92.